Roche could increase U.S. output 'overnight,' CEO says amid tariff wars
As economic uncertainty continues to roil the stock market, a biotech giant with a significant presence in Indianapolis reports a strong start to 2025 with few concerns about how the Trump administration's potential tariffs could impact the company…